Automated Technology Could Reduce Need for Human Review of Cervical Cancer Samples

by Kathy Jones on  July 14, 2011 at 7:44 PM News on IT in Healthcare
RSS Email Print This Page Comment bookmark
Font : A-A+

The number of cervical cancer screening samples needing human review could be cut down by as much as 25 percent after the United Kingdom National Health Service Cancer Screening Programmes (NHSCSP) approved the use of an automated technology to screen the samples.
 Automated Technology Could Reduce Need for Human Review of Cervical Cancer Samples
Automated Technology Could Reduce Need for Human Review of Cervical Cancer Samples

Developed by Source BioScience, the BD FocalPoint can automatically screen cervical cancer samples and provides a "no further review necessary" signal should it find no problems with the samples.

The automated service is expected to cut down the number of samples that require human review by nearly 900,000 with over 3.6 million samples being reviewed every year in England and Wales.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Women and Cancer Cancer and Homeopathy Cervical Cancer Cancer Facts Cancer Tattoos A Body Art Uterine Cancer AIDS-HIV-Cancer Health Screening for Women Pap smear and Cervical Cancer Screening 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive